THE PRESENCE OF M2 MACROPHAGES IN OVARIAN CANCER IS INFLUENCED BY TUMOR STAGE AND GRADE, NOT BY THE ADMINISTRATION OF PACLITAXEL-CARBOPLATIN: A PILOT STUDY

被引：0
|
作者：
Baert, T. [1 ]
Mathivet, T. [2 ]
Van Hoylandt, A. [3 ]
Vergote, I. [1 ]
Coosemans, A. [1 ]
机构：
[1] Univ Hosp Leuven, Gynaecol & Obstet, Leuven, Belgium
[2] Katholieke Univ Leuven, Vesalius Res Ctr, Dept Oncol, Lab Vasc Patterning, Leuven, Belgium
[3] Katholieke Univ Leuven, Dept Oncol, Lab Gynaecol Oncol, Leuven, Belgium
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2015年 / 25卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ESGO-1130
引用
收藏
页码：1282 / 1282
页数：1
相关论文
共 50 条
  • [31] Phase III study of valspodar (PSC 833) combined with paclitaxel and carboplatin compared with paclitaxel and carboplatin alone in patients with stage IV or suboptimally debulked stage III epithelial ovarian cancer or primary peritoneal cancer
    Lhomme, Catherine
    Joly, Florence
    Walker, Joan L.
    Lissoni, Andrea A.
    Nicoletto, Maria O.
    Manikhas, Gregory M.
    Baekelandt, Mark M. O.
    Gordon, Alan N.
    Fracasso, Paula M.
    Mietlowski, William L.
    Jones, Gary J.
    Dugan, Margaret H.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (16) : 2674 - 2682
  • [32] Dasatinib, paclitaxel and carboplatin in women with advanced-stage and recurrent endometrial cancer: A pilot clinical and translational study
    Coleman, R. L.
    Hu, W.
    Soliman, P. T.
    Nick, A. M.
    Ramirez, P. T.
    Westin, S. N.
    Zu, Z.
    Schmeler, K. M.
    Bodurka, D. C.
    Meyer, L. A.
    Sood, A. K.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 35 - 36
  • [33] Dasatinib, paclitaxel, and carboplatin in women with advanced-stage or recurrent endometrial cancer: A pilot clinical and translational study
    Coleman, Robert L.
    Hu, Wei
    Soliman, Pamela
    Nick, Alpa
    Ramirez, Pedro T.
    Westin, Shannon N.
    Garcia, Michael E.
    Zhu, Zhifei
    Palancia, Julieta
    Fellman, Bryan M.
    Yuan, Ying
    Ram, Prahlad
    Bischoff, Farideh
    Schmeler, Kathleen
    Bodurka, Diane
    Meyer, Larissa A.
    Sood, Anil K.
    GYNECOLOGIC ONCOLOGY, 2021, 161 (01) : 104 - 112
  • [34] Paclitaxel (175 mg/m2) plus carboplatin (6 AUC) versus paclitaxel (225 mg/m2)plus carboplatin (6 AUG) in advanced non-small-cell lung cancer (NSCLC):: A multicenter randomized trial
    Kosmidis, P
    Mylonakis, N
    Skarlos, D
    Samantas, E
    Dimopoulos, M
    Papadimitriou, C
    Kalophonos, C
    Pavlidis, N
    Nikolaidis, C
    Papaconstantinou, C
    Fountzilas, G
    ANNALS OF ONCOLOGY, 2000, 11 (07) : 799 - 805
  • [35] TUMOR-ASSOCIATED MACROPHAGES OF THE M2 PHENOTYPE ENDORSE COLORECTAL CANCER METASTASIS
    Hu, Wangxiong
    GUT, 2019, 68 : A29 - A29
  • [36] β-elemene inhibits tumor-promoting effect of M2 macrophages in lung cancer
    Yu, Xiaomu
    Xu, Maoyi
    Li, Na
    Li, Zongjuan
    Li, Hongye
    Shao, Shujuan
    Zou, Kun
    Zou, Lijuan
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 490 (02) : 514 - 520
  • [37] A pilot study of nivolumab in combination with front-line neoadjuvant dose-dense paclitaxel and carboplatin chemotherapy in patients with high-grade serous ovarian cancer
    Friedman, C. F.
    Snyder, A.
    Abu-Rustum, N. R.
    Broach, V.
    Brown, C. L.
    Bykov, Y.
    Cadoo, K. A.
    Chi, D. S.
    Cohen, S.
    Eid, K. T.
    Gardner, G. J.
    Grisham, R. N.
    Holland, A.
    Hollmann, T. J.
    Iasonos, A.
    Leitao, M. M., Jr.
    Roche, K. Long
    O'Cearbhaill, R. E.
    Tew, W. P.
    Weissblum, S.
    Wibmer, A. G.
    Zhou, Q.
    Zivanovic, O.
    Aghajanian, C.
    Zamarin, D.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 4 - 4
  • [38] MiR-21 modulates the polarization of macrophages and increases the effects of M2 macrophages on promoting the chemoresistance of ovarian cancer
    An, Yuanyuan
    Yang, Qing
    LIFE SCIENCES, 2020, 242
  • [39] Paclitaxel (175 mg/m(2)) plus carboplatin versus paclitaxel (225 mg/m(2)) plus carboplatin in non-small cell lung cancer: A randomized study
    Kosmidis, P
    Mylonakis, N
    Fountzilas, G
    Samantas, E
    Athanassiadis, A
    Pavlidis, N
    Skarlos, D
    SEMINARS IN ONCOLOGY, 1997, 24 (04) : 30 - 33
  • [40] A study of evolutionary dynamics induced by carboplatin, olaparib and paclitaxel in high-grade serous ovarian cancer cell line models
    Ingles, Alvaro H.
    Garces, Russo
    Milite, Salvatore
    Fernandez-Mateos, Javier
    Chen, Bingjie
    Pickard, Lisa
    Stewart, Adam
    Sanchez, Sara Diaz
    Lau, Rachel
    Oliveira, Erica
    Banerjee, Susana
    Sottoriva, Andrea
    Banerji, Udai
    CANCER RESEARCH, 2022, 82 (12)
12345